These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 39358480)

  • 1. Targeting senescent cells in aging and COVID-19: from cellular mechanisms to therapeutic opportunities.
    Yu Y; Lin K; Wu H; Hu M; Yang X; Wang J; Grillari J; Chen J
    Cell Regen; 2024 Oct; 13(1):20. PubMed ID: 39358480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.
    Romashkan S; Chang H; Hadley EC
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1144-1152. PubMed ID: 33528569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
    Murakami T; Inagaki N; Kondoh H
    Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.
    Roth-Walter F; Adcock IM; Benito-Villalvilla C; Bianchini R; Bjermer L; Caramori G; Cari L; Chung KF; Diamant Z; Eguiluz-Gracia I; Knol EF; Jesenak M; Levi-Schaffer F; Nocentini G; O'Mahony L; Palomares O; Redegeld F; Sokolowska M; Van Esch BCAM; Stellato C
    Allergy; 2024 May; 79(5):1089-1122. PubMed ID: 38108546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senopathies-Diseases Associated with Cellular Senescence.
    Lushchak O; Schosserer M; Grillari J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of p21 in cellular senescence and aging-related diseases.
    Yan J; Chen S; Yi Z; Zhao R; Zhu J; Ding S; Wu J
    Mol Cells; 2024 Sep; 47(11):100113. PubMed ID: 39304134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cellular senescence in metabolic disease.
    Palmer AK; Tchkonia T; Kirkland JL
    Mol Metab; 2022 Dec; 66():101601. PubMed ID: 36116755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategies targeting cellular senescence for cancer and other diseases.
    Wang X; Fukumoto T; Noma KI
    J Biochem; 2024 Apr; 175(5):525-537. PubMed ID: 38366629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies.
    Zheng L; He S; Wang H; Li J; Liu Y; Liu S
    Aging Dis; 2024 Feb; ():. PubMed ID: 38421832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cellular senescence in female reproductive aging and the potential for senotherapeutic interventions.
    Secomandi L; Borghesan M; Velarde M; Demaria M
    Hum Reprod Update; 2022 Feb; 28(2):172-189. PubMed ID: 34918084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Senescent Cells as Therapy for CKD.
    Mylonas KJ; Ferenbach DA
    Kidney360; 2024 Jan; 5(1):142-151. PubMed ID: 38049936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of gingerenone A as a novel senolytic compound.
    Moaddel R; Rossi M; Rodriguez S; Munk R; Khadeer M; Abdelmohsen K; Gorospe M; Ferrucci L
    PLoS One; 2022; 17(3):e0266135. PubMed ID: 35349590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the perspectives of pharmaceutical experts and healthcare practitioners on senolytic drugs for vascular aging-related disorder: a qualitative study.
    Wong LP; Alias H; Tan KM; Wong PF; Murugan DD; Hu Z; Lin Y
    Front Pharmacol; 2023; 14():1254470. PubMed ID: 37869747
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 and cellular senescence.
    Schmitt CA; Tchkonia T; Niedernhofer LJ; Robbins PD; Kirkland JL; Lee S
    Nat Rev Immunol; 2023 Apr; 23(4):251-263. PubMed ID: 36198912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senotherapeutics: Targeting senescent cells for the main age-related diseases.
    Boccardi V; Mecocci P
    Mech Ageing Dev; 2021 Jul; 197():111526. PubMed ID: 34166689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease.
    Lynch SM; Guo G; Gibson DS; Bjourson AJ; Rai TS
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cellular senescence based on interorganelle communication, multilevel proteostasis, and metabolic control.
    Cavinato M; Madreiter-Sokolowski CT; Büttner S; Schosserer M; Zwerschke W; Wedel S; Grillari J; Graier WF; Jansen-Dürr P
    FEBS J; 2021 Jun; 288(12):3834-3854. PubMed ID: 33200494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction.
    Suda M; Paul KH; Tripathi U; Minamino T; Tchkonia T; Kirkland JL
    Endocr Rev; 2024 Sep; 45(5):655-675. PubMed ID: 38500373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the emerging bidirectional association between inflamm-aging and cellular senescence in organismal aging and disease.
    Sharma R
    Cell Biochem Funct; 2024 Mar; 42(2):e3970. PubMed ID: 38456500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senolytics: Potential for Alleviating Diabetes and Its Complications.
    Palmer AK; Tchkonia T; Kirkland JL
    Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33705532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.